EGF and triple-negative breast carcinoma: Additionally, to explore their potential for medical applications, EGF-polymeric micelles, tethering EGF on polymeric micelles, were administered to MDA-MB468 human triple-negative breast cancer cells, which are typically resistant to EGFR inhibitors, to investigate their time-dependent anti-cancer activities and impact of particle size on these activities.